297.38 USD
+2.76 (+0.94%)
At close: Feb 5, 2026
299.21 USD
+1.83 (+0.62%)
After Hours: 2/5/2026, 8:17:07 PM
ChartMill assigns a Buy % Consensus number of 70% to CME. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 297.93. This target is 0.18% above the current price.
- CME was analyzed by 20 analysts. The buy percentage consensus is at 70. So analysts seem to be have mildly positive about CME.
- In the previous month the buy percentage consensus was at a similar level.
- CME was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-02-05 | TD Cowen | Maintains | Buy -> Buy |
| 2026-02-05 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2026-02-05 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-05 | JP Morgan | Maintains | Underweight -> Underweight |
| 2026-02-05 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2026-01-15 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2026-01-14 | TD Cowen | Upgrade | Hold -> Buy |
| 2025-12-22 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-12-12 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-13 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-10-23 | UBS | Maintains | Neutral -> Neutral |
| 2025-10-23 | Deutsche Bank | Upgrade | Hold -> Buy |
| 2025-10-23 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-10-13 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-10-08 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-01 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-09-25 | JP Morgan | Maintains | Underweight -> Underweight |
| 2025-09-25 | Citigroup | Upgrade | Neutral -> Buy |
| 2025-09-08 | UBS | Maintains | Neutral -> Neutral |
| 2025-07-24 | UBS | Downgrade | Buy -> Neutral |
| 2025-07-24 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-07-24 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-15 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-07-10 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-03 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-06-04 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-04-25 | UBS | Maintains | Buy -> Buy |
| 2025-04-24 | Keefe, Bruyette & Woods | Maintains | Market Perform -> Market Perform |
| 2025-04-24 | JP Morgan | Maintains | Underweight -> Underweight |
| 2025-04-24 | Morgan Stanley | Maintains | Overweight -> Overweight |
CME GROUP INC / CME FAQ
What is the average price target for CME GROUP INC (CME) stock?
20 analysts have analysed CME and the average price target is 297.93 USD. This implies a price increase of 0.18% is expected in the next year compared to the current price of 297.38.
What is the consensus rating for CME GROUP INC (CME) stock?
The consensus rating for CME GROUP INC (CME) is 70 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
What is the number of analysts for CME stock?
The number of analysts covering CME GROUP INC (CME) is 20.